Works matching IS 00071188 AND DT 2022 AND VI 179 AND IP 2

Results: 11

Osteosarcoma mechanobiology and therapeutic targets.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 2, p. 201, doi. 10.1111/bph.15713

By:

Shoaib, Zunaira;
Fan, Timothy M.;
Irudayaraj, Joseph M. K.

Publication type:

Article

Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: Preclinical and clinical evidence in osteoarthritis and gout.

Published in:

2022

By:

Franco‐Trepat, Eloi;
Alonso‐Pérez, Ana;
Guillán‐Fresco, María;
Jorge‐Mora, Alberto;
Crespo‐Golmar, Antia;
López‐Fagúndez, Miriam;
Pazos‐Pérez, Andrés;
Gualillo, Oreste;
Belén Bravo, Susana;
Gómez Bahamonde, Rodolfo;
Franco-Trepat, Eloi;
Alonso-Pérez, Ana;
Guillán-Fresco, María;
Jorge-Mora, Alberto;
Crespo-Golmar, Antia;
López-Fagúndez, Miriam;
Pazos-Pérez, Andrés

Publication type:

journal article

Calycosin ameliorates atherosclerosis by enhancing autophagy via regulating the interaction between KLF2 and MLKL in apolipoprotein E gene‐deleted mice.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 2, p. 252, doi. 10.1111/bph.15720

By:

Ma, Chuanrui;
Wu, Han;
Yang, Guangyan;
Xiang, Jiaqing;
Feng, Ke;
Zhang, Jing;
Hua, Yunqing;
Kang, Lin;
Fan, Guanwei;
Yang, Shu

Publication type:

Article

Cardiovascular and renal effects of novel nonpeptide nociceptin opioid peptide receptor agonists.

Published in:

2022

By:

Denys, Ian B.;
Gao, Juan;
Sutphen, Jane C.;
Zaveri, Nurulain T.;
Kapusta, Daniel R.

Publication type:

journal article

The dietary fibre rhamnogalacturonan improves intestinal epithelial barrier function in a microbiota‐independent manner.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 2, p. 337, doi. 10.1111/bph.15739

By:

Baggio, Cristiane H.;
Shang, Judie;
Gordon, Marilyn H.;
Stephens, Matthew;
von der Weid, Pierre Yves;
Nascimento, Adamara M.;
Román, Yony;
Cipriani, Thales R.;
MacNaughton, Wallace K.

Publication type:

Article

Targeting the OXE receptor with a selective antagonist inhibits allergen‐induced pulmonary inflammation in non‐human primates.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 2, p. 322, doi. 10.1111/bph.15721

By:

Cossette, Chantal;
Miller, Lisa A.;
Ye, Qiuji;
Chourey, Shishir;
Reddy, Chintam Nagendra;
Rokach, Joshua;
Powell, William S.

Publication type:

Article

Hypothesis: Possible influence of antivector immunity and SARS‐CoV‐2 variants on efficacy of ChAdOx1 nCoV‐19 vaccine.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 2, p. 218, doi. 10.1111/bph.15620

By:

Zamai, Loris;
Rocchi, Marco B. L.

Publication type:

Article

Cyclic helix B peptide promotes random‐pattern skin flap survival via TFE3‐mediated enhancement of autophagy and reduction of ROS levels.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 2, p. 301, doi. 10.1111/bph.15702

By:

Lou, Junsheng;
Zhang, Haojie;
Qi, Jianjun;
Xu, Yu;
Wang, Xingyu;
Jiang, Jingtao;
Hu, Xinli;
Ni, Libin;
Cai, Yuepiao;
Wang, Xiangyang;
Gao, Weiyang;
Xiao, Jian;
Zhou, Kailiang

Publication type:

Article

Role of Na<sub>V</sub>1.7 in action potential conduction along human bronchial vagal afferent C‐fibres.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 2, p. 242, doi. 10.1111/bph.15686

By:

Kollarik, Marian;
Ru, Fei;
Pavelkova, Nikoleta;
Mulcahy, John;
Hunter, John;
Undem, Bradley J.

Publication type:

Article

Sex differences in the effect of chronic delivery of the buprenorphine analogue BU08028 on heroin relapse and choice in a rat model of opioid maintenance.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 2, p. 227, doi. 10.1111/bph.15679

By:

Bossert, Jennifer M.;
Townsend, E. Andrew;
Altidor, Lindsay K‐P;
Fredriksson, Ida;
Shekara, Aniruddha;
Husbands, Stephen;
Sulima, Agnieszka;
Rice, Kenner C.;
Banks, Matthew L.;
Shaham, Yavin

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2022, v. 179, n. 2, p. 199, doi. 10.1111/bph.15545
Publication type:: Article